BioMarin Pharmaceutical, Inc. (BMRN)
54.60
+1.36
(+2.55%)
USD |
NASDAQ |
May 06, 16:00
54.80
+0.20
(+0.37%)
After-Hours: 07:07
BioMarin Pharmaceutical Cash from Investing (Quarterly) : 725.53M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -6.494M |
| Ionis Pharmaceuticals, Inc. | 536.82M |
| Mirum Pharmaceuticals, Inc. | 1.006M |
| Hims & Hers Health, Inc. | -83.68M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 220.65M |
| Cash from Financing (Quarterly) | 813.17M |
| Free Cash Flow | 759.12M |
| Free Cash Flow Per Share (Quarterly) | 1.010 |
| Free Cash Flow to Equity (Quarterly) | -603.66M |
| Free Cash Flow to Firm (Quarterly) | 210.91M |
| Free Cash Flow Yield | 7.14% |